The Role of Collagen Triple Helix Repeat Containing 1 in Injured Arteries, Collagen Expression, and Transforming Growth Factor β Signaling

Trends in Cardiovascular Medicine

Volumn 17, Issue 6, 2007, Pages 202-205

  LeClair, Renée ^a   Lindner, Volkhard ^a  

^a Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TRIPLE HELIX REPEAT CONTAINING PROTEIN 1; GENE PRODUCT; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTERY INJURY; GENE ACTIVATION; GENE CONTROL; GENE INACTIVATION; HEART MUSCLE FIBROSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR FIBROSIS; VASCULAR SURGERY;

CARDIOVASCULAR DISEASES; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; HUMANS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTORS;

EID: 34447649923     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.05.004     Document Type: Review

References (16)

1. Bissell D.M. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 33 (2001) 179-190
2. Durmus T., LeClair R.J., Park K.S., et al. Expression analysis of the novel gene collagen triple helix repeat containing 1 (Cthrc1). Gene Expr Patterns 6 (2006) 935-940
3. Ghosh A.K. Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood) 227 (2002) 301-314
4. Janssens K., Ten Dijke P., Janssens S., and Van Hul W. Transforming growth factor-beta1 to the bone. Endocr Rev 26 (2005) 743-774
5. Kumar A., and Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17 (1997) 2238-2244
6. LeClair R.J., Durmus T., Wang Q., et al. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res 100 (2007) 826-833
7. Lindner V. Vascular repair processes mediated by transforming growth factor-beta. Z Kardiol 90 Suppl 3 (2001) 17-22
8. Majesky M.W., Lindner V., Twardzik D.R., et al. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 88 (1991) 904-910
9. Mallawaarachchi C.M., Weissberg P.L., and Siow R.C. Smad7 gene transfer attenuates adventitial cell migration and vascular remodeling after balloon injury. Arterioscler Thromb Vasc Biol 25 (2005) 1383-1387
10. Pannu J., Nakerakanti S., Smith E., et al. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem 282 (2007) 10405-10413
11. Pyagay P., Heroult M., Wang Q., et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res 96 (2005) 261-268
12. Ryan S.T., Koteliansky V.E., Gotwals P.J., and Lindner V. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res 40 (2003) 37-46
13. Smith J.D., Bryant S.R., Couper L.L., et al. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. Circ Res 84 (1999) 1212-1222
14. Tang L., Dai D.L., Su M., et al. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res 12 (2006) 3716-3722
15. Wang Y., Xu A., Knight C., et al. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 277 (2002) 19521-19529
16. Wong G.W., Wang J., Hug C., et al. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A 101 (2004) 10302-10307